研究心力衰竭中的NF-κB信号通路:探索潜在的治疗方法
1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Heliyon
|December 24, 2024
概括
心力衰竭 (HF) 是与炎症相关的日益严重的流行病. 针对核因子kappa B (NF-κB) 途径提供了潜在的治疗策略,以减少心脏纤维化和改善HF患者的结果.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康问题,也是导致死亡的主要原因,由人口老龄化加剧.
- 支持炎症的细胞因子和细胞并发症会使HF恶化,强调需要更深入地理解机制.
- 核因子kappa B (NF-κB) 信号通路与炎症,细胞存活和心脏过程有关.
研究的目的:
- 审查NF-κB信号通路在心力衰竭的发病过程中的多方面的作用.
- 探索针对NF-κB的潜在治疗策略,用于治疗HF.
- 为了确定科学差距,了解NF-κB的高频分子机制在高频.
主要方法:
- 对研究NF-κB信号在心血管疾病和心力衰竭中的研究进行文献综述.
- 分析NF-κB在心脏再生,亡,热亡和纤维化中的作用.
- 检查针对NF-κB通路的治疗干预措施.
主要成果:
- 通过调节矩阵金属蛋白酶和纤维化介质,NF-κB信号影响心脏功能和心脏衰竭.
- 该途径调节心肌细胞活动,亡和热亡,影响整体心脏功能.
- NF-κB激活与增加的促炎性细胞因子有关,有助于HF的不良临床结果.
结论:
- 用抗炎药物或基因调制向NF-κB通路,为HF提供了有希望的治疗途径.
- 通过调节NF-κB,可以减少心肌纤维化和改善心肌纤维化结果.
- 进一步研究HF中NF-κB的精确分子机制对于开发创新的治疗方法至关重要.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:22Heart Failure Drugs: β-Blockers
259
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
259
01:26Heart Failure Drugs: Inotropic Agents
398
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
398
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37